Novo Nordisk is facing the prospect of intensifying competition in the Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed.
#novonordisk #wegovyweightloss #wgovy #ozempicweightloss #ozempic #china #drugmakers #News #Reuters #Newsfeed
Read the story here: https://reut.rs/3KCS3gN
???? Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
#novonordisk #wegovyweightloss #wgovy #ozempicweightloss #ozempic #china #drugmakers #News #Reuters #Newsfeed
Read the story here: https://reut.rs/3KCS3gN
???? Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
- Category
- World
- Tags
- reuters, news, world news today
Sign in or sign up to post comments.
Be the first to comment